These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25414439)

  • 1. Red cells from ferrochelatase-deficient erythropoietic protoporphyria patients are resistant to growth of malarial parasites.
    Smith CM; Jerkovic A; Puy H; Winship I; Deybach JC; Gouya L; van Dooren G; Goodman CD; Sturm A; Manceau H; McFadden GI; David P; Mercereau-Puijalon O; Burgio G; McMorran BJ; Foote SJ
    Blood; 2015 Jan; 125(3):534-41. PubMed ID: 25414439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Griseofulvin impairs intraerythrocytic growth of Plasmodium falciparum through ferrochelatase inhibition but lacks activity in an experimental human infection study.
    Smith CM; Jerkovic A; Truong TT; Foote SJ; McCarthy JS; McMorran BJ
    Sci Rep; 2017 Feb; 7():41975. PubMed ID: 28176804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heme biosynthesis by the malarial parasite. Import of delta-aminolevulinate dehydrase from the host red cell.
    Bonday ZQ; Taketani S; Gupta PD; Padmanaban G
    J Biol Chem; 1997 Aug; 272(35):21839-46. PubMed ID: 9268315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability.
    Barman-Aksözen J; Minder EI; Schubiger C; Biolcati G; Schneider-Yin X
    Blood Cells Mol Dis; 2015 Jan; 54(1):71-7. PubMed ID: 25179834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice.
    Barman-Aksözen J; C Wiek P; Bansode VB; Koentgen F; Trüb J; Pelczar P; Cinelli P; Schneider-Yin X; Schümperli D; Minder EI
    Dis Model Mech; 2017 Mar; 10(3):225-233. PubMed ID: 28093505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of murine erythropoietic protoporphyria-associated skin photosensitivity and liver disease by dermal and hepatic ferrochelatase.
    Pawliuk R; Tighe R; Wise RJ; Mathews-Roth MM; Leboulch P
    J Invest Dermatol; 2005 Jan; 124(1):256-62. PubMed ID: 15654982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malaria parasite-synthesized heme is essential in the mosquito and liver stages and complements host heme in the blood stages of infection.
    Nagaraj VA; Sundaram B; Varadarajan NM; Subramani PA; Kalappa DM; Ghosh SK; Padmanaban G
    PLoS Pathog; 2013; 9(8):e1003522. PubMed ID: 23935500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital erythropoietic porphyria and erythropoietic protoporphyria: Identification of 7 uroporphyrinogen III synthase and 20 ferrochelatase novel mutations.
    Weiss Y; Balwani M; Chen B; Yasuda M; Nazarenko I; Desnick RJ
    Mol Genet Metab; 2019 Nov; 128(3):358-362. PubMed ID: 30454868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel genetic technique in Plasmodium berghei allows liver stage analysis of genes required for mosquito stage development and demonstrates that de novo heme synthesis is essential for liver stage development in the malaria parasite.
    Rathnapala UL; Goodman CD; McFadden GI
    PLoS Pathog; 2017 Jun; 13(6):e1006396. PubMed ID: 28617870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferrochelatase consisting of wild-type and mutated subunits from patients with a dominant-inherited disease, erythropoietic protoporphyria, is an active but unstable dimer.
    Ohgari Y; Sawamoto M; Yamamoto M; Kohno H; Taketani S
    Hum Mol Genet; 2005 Jan; 14(2):327-34. PubMed ID: 15574461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal bone marrow transplantation prevents liver disease in a murine model of erythropoietic protoporphyria.
    Duchartre Y; Petit N; Moya C; Lalanne M; Dubus P; Verneuil Hd; Moreau-Gaudry F; Richard E
    J Hepatol; 2011 Jul; 55(1):162-70. PubMed ID: 21145811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mouse model provides evidence that genetic background modulates anemia and liver injury in erythropoietic protoporphyria.
    Abitbol M; Bernex F; Puy H; Jouault H; Deybach JC; Guénet JL; Montagutelli X
    Am J Physiol Gastrointest Liver Physiol; 2005 Jun; 288(6):G1208-16. PubMed ID: 15677551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and characterization of erythropoietic protoporphyric heterodimeric ferrochelatases.
    Najahi-Missaoui W; Dailey HA
    Blood; 2005 Aug; 106(3):1098-104. PubMed ID: 15831704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietic protoporphyria a clinical and molecular study from Lebanon: Ferrochelatase a potential tumor suppressor gene in colon cancer.
    Kadara H; Nemer G; Safi R; Rebeiz N; Daou L; Delbani D; Btadini W; Abbas O; Tofaili M; Bitar F; Kibbi AG; Shimomura Y; Kurban M
    Clin Genet; 2017 Nov; 92(5):495-502. PubMed ID: 28075030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical abnormality in erythropoietic protoporphyria: cause and consequences.
    Bloomer JR; Wang Y; Singhal A; Risheg H
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S36-40. PubMed ID: 16819399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease.
    Tutois S; Montagutelli X; Da Silva V; Jouault H; Rouyer-Fessard P; Leroy-Viard K; Guénet JL; Nordmann Y; Beuzard Y; Deybach JC
    J Clin Invest; 1991 Nov; 88(5):1730-6. PubMed ID: 1939658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity.
    Barman-Aksoezen J; Girelli D; Aurizi C; Schneider-Yin X; Campostrini N; Barbieri L; Minder EI; Biolcati G
    J Inherit Metab Dis; 2017 May; 40(3):433-441. PubMed ID: 28185024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The heme biosynthesis pathway is essential for Plasmodium falciparum development in mosquito stage but not in blood stages.
    Ke H; Sigala PA; Miura K; Morrisey JM; Mather MW; Crowley JR; Henderson JP; Goldberg DE; Long CA; Vaidya AB
    J Biol Chem; 2014 Dec; 289(50):34827-37. PubMed ID: 25352601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the phenotype in dominant erythropoietic protoporphyria by a low expression of the normal ferrochelatase allele.
    Gouya L; Deybach JC; Lamoril J; Da Silva V; Beaumont C; Grandchamp B; Nordmann Y
    Am J Hum Genet; 1996 Feb; 58(2):292-9. PubMed ID: 8571955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing of glycine transport inhibitors for the treatment of erythropoietic protoporphyria.
    Halloy F; Iyer PS; Ghidini A; Lysenko V; Barman-Aksözen J; Grubenmann CP; Jucker J; Wildner-Verhey van Wijk N; Ruepp MD; Minder EI; Minder AE; Schneider-Yin X; Theocharides APA; Schümperli D; Hall J
    Cell Chem Biol; 2021 Aug; 28(8):1221-1234.e6. PubMed ID: 33756123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.